In a testament to how good a year 2017 was for some health-care stocks, four health companies are among the S&P 500s 20 biggest gains, three of them businesses with less than $3 billion in annual revenue.
Trump has given conflicting signals in the past weeks on whether he would let the government intervene directly in drug prices to reduce health-care costs.
DebugScreen: mobile
{
"author": {
"name": "Cecile Daurat",
"webUrl": "/author/profile/cecile-daurat/",
"description": "",
"imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
"estimate": 3,
"social": [],
"articles": [
{
"uri": "/2017/12/29/health-stock-winners-and-losers-in-2017/",
"title": "Health stock winners and losers in 2017",
"byline": "Cecile Daurat",
"kicker": "",
"prettyDate": "December 29, 2017",
"timeToRead": "4 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/cecile-daurat/",
"name": "Cecile Daurat"
}
],
"kickerNode": [],
"summary": "In a testament to how good a year 2017 was for some health-care stocks, four health companies are among the S&P 500s 20 biggest gains, three of them businesses with less than $3 billion in annual revenue.",
"body": null
},
{
"uri": "/2017/02/14/cigna-faces-off-with-anthem/",
"title": "Cigna faces off with Anthem",
"byline": "Cecile Daurat",
"kicker": "",
"prettyDate": "February 14, 2017",
"timeToRead": "2 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/cecile-daurat/",
"name": "Cecile Daurat"
}
],
"kickerNode": [],
"summary": "Cigna is looking for nearly $2 billion in a 'breakup fee' and an additional $13 billion in damages.",
"body": null
},
{
"uri": "/2017/02/08/trump-sinks-pharma-stocks-on-medicaid-drug-price-n/",
"title": "Trump sinks pharma stocks on Medicaid drug price negotiation",
"byline": "Cecile Daurat, Toluse Olorunnipa",
"kicker": "",
"prettyDate": "February 08, 2017",
"timeToRead": "3 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/cecile-daurat-toluse-olorunnipa/",
"name": "Cecile Daurat, Toluse Olorunnipa"
}
],
"kickerNode": [],
"summary": "Trump has given conflicting signals in the past weeks on whether he would let the government intervene directly in drug prices to reduce health-care costs.",
"body": null
}
]
}
}